AN EXCLUSIVE EVENT FOR A FAST-GROWING SEGMENT
Life Sciences is not exclusively medtech and biotech. There is a rapidly expanding segment powering the entire ecosystem: tools built for labs and R&D — serving biopharma, academia, research institutes, and innovation teams.
Biotool companies may not treat patients directly. They often avoid the long CE/FDA regulatory pathways. Yet they remain under-recognized, sometimes misclassified, and not always connected to the right investors, customers, and partners.
Call it:
- Tools for Life Sciences
- Bio-enabling technologies (BET)
- Biotechnology tools
We are putting a clear name on it and building the community: BIOTOOL.
WHO SHOULD JOIN?
- Start-ups developing biotools looking for sharper visibility and the right connections
- Investors seeking a clearer understanding of this segment’s dynamics and growth potential
- Coaches, experts and ecosystem enablers supporting Life Sciences ventures
- Anyone who wants to help shape and structure this space
